Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Medication Adherence in People With Parkinson Disease

Shin JY, Habermann B.

J Neurosci Nurs. 2016 Jul-Aug;48(4):185-94. doi: 10.1097/JNN.0000000000000198.

Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients

Hida K, Nonokuma M, Kuwabara Y, Tani T, Takano K, Yoshimitsu K.

Ann Nucl Med. 2016 Aug;30(7):477-83. doi: 10.1007/s12149-016-1085-8. Epub 2016 May 25.

Surgical aspects of atrial arrhythmia : Right atrial ablation and anti-arrhythmic surgery in congenital heart disease

Uemura H.

Herzschrittmacherther Elektrophysiol. 2016 Jun;27(2):137-42. doi: 10.1007/s00399-016-0434-6. Epub 2016 May 25.

A review of disease progression models of Parkinson's disease and applications in clinical trials

Venuto CS, Potter NB, Dorsey ER, Kieburtz K.

Mov Disord. 2016 Jul;31(7):947-956. doi: 10.1002/mds.26644. Epub 2016 May 26.

Motor subtype in Parkinson's disease: Different disorders or different stages of disease?

Nutt JG.

Mov Disord. 2016 Jul;31(7):957-61. doi: 10.1002/mds.26657. Epub 2016 May 26.

A Pilot Clinical Trial to Objectively Assess the Efficacy of Electroacupuncture on Gait in Patients with Parkinson's Disease Using Body Worn Sensors

Lei H, Toosizadeh N, Schwenk M, Sherman S, Karp S, Sternberg E, Najafi B.

PLoS One. 2016 May 26;11(5):e0155613. doi: 10.1371/journal.pone.0155613. eCollection 2016.

Deep brain stimulation for the treatment of uncommon tremor syndromes

Ramirez-Zamora A, Okun MS.

Expert Rev Neurother. 2016 Aug;16(8):983-97. doi: 10.1080/14737175.2016.1194756. Epub 2016 Jun 9.

Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders

Hong H, Kim BS, Im HI.

Int Neurourol J. 2016 May;20(Suppl 1):S2-7. doi: 10.5213/inj.1632604.302. Epub 2016 May 26.

Alexithymia in Parkinson's disease: a point of view on current evidence

Costa A, Caltagirone C.

Neurodegener Dis Manag. 2016 Jun;6(3):215-22. doi: 10.2217/nmt-2016-0001. Epub 2016 May 27.

Nondopaminergic treatments for Parkinson's disease: current and future prospects

Freitas ME, Fox SH.

Neurodegener Dis Manag. 2016 Jun;6(3):249-68. doi: 10.2217/nmt-2016-0005. Epub 2016 May 27.

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

Ivachtchenko AV, Lavrovsky Y, Okun I.

J Alzheimers Dis. 2016 May 25;53(2):583-620. doi: 10.3233/JAD-151146.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J.

Alzheimers Dement. 2016 Nov;12(11):1125-1131. doi: 10.1016/j.jalz.2016.04.003. Epub 2016 May 24.

Polypharmacology of dopamine receptor ligands

Butini S, Nikolic K, Kassel S, Brückmann H, Filipic S, Agbaba D, Gemma S, Brogi S, Brindisi M, Campiani G, Stark H.

Prog Neurobiol. 2016 Jul;142:68-103. doi: 10.1016/j.pneurobio.2016.03.011. Epub 2016 May 24.

Movement Disorders: A Brief Guide in Medication Management

Julius A, Longfellow K.

Med Clin North Am. 2016 Jul;100(4):733-61. doi: 10.1016/j.mcna.2016.03.002. Epub 2016 Apr 19.

Linking mitochondrial dynamics to mitochondrial protein quality control

Haroon S, Vermulst M.

Curr Opin Genet Dev. 2016 Jun;38:68-74. doi: 10.1016/j.gde.2016.04.004. Epub 2016 May 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias